What are the first-line treatment options for newly diagnosed DLBCL, and why are they chosen?

What are the first-line treatment options for newly diagnosed DLBCL, and why are they chosen?
Myeloma Roundtable Q&A with Faculty- CAR-T, ASCT, Treatments, Side Effects.
What is the role of rituximab (the "R" in R-CHOP) in treating newly diagnosed DLBCL? What are its side effects and how are they managed?
Multiple Myeloma Q & A with Dr. Matsui for the Newly Diagnosed Population | William Matsui, MD
Navigating Risks and Rewards- Immunotherapies in Myeloma Care | Adam Cohen, MD
Myeloma Philadelphia HealthTree Round Table - Audience Q&A with Faculty